Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Israel

Showing results (161-170 of 322) with videos related to

Pageof 33
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 4, 2023
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical TrialsJonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2020
Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohortAnnette T Hastie, David T Mauger, Loren C Denlinger, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2006
IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expressionSally E Wenzel, Silvana Balzar, Elizabeth Ampleford, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2011
Obesity and asthma: an association modified by age of asthma onsetFernando Holguin, Eugene R Bleecker, William W Busse, et al.
BMC Pulmonary Medicine|May 18, 2016
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the NetherlandsThys van der Molen, Dirkje S Postma, Richard J Martin, et al.
The Lancet. Respiratory Medicine|March 14, 2014
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic studyVictor E Ortega, Gregory A Hawkins, Wendy C Moore, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2021
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research ProgramAnnette T Hastie, David T Mauger, Loren C Denlinger, et al.
BMC Pulmonary Medicine|July 25, 2016
Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the NetherlandsThys van der Molen, Dirkje S Postma, Richard J Martin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 22, 2018
Predictors of inhaled corticosteroid taper failure in adults with asthmaJuan Carlos Cardet, Christopher D Codispoti, Tonya S King, et al.
Human Molecular Genetics|May 7, 2004
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroidsKelan G Tantisira, Stephen Lake, Eric S Silverman, et al.
Pageof 33

Showing results (161-170 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Respiratory and Critical Care Medicine|April 4, 2023
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical TrialsJonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2020
Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohortAnnette T Hastie, David T Mauger, Loren C Denlinger, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2006
IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expressionSally E Wenzel, Silvana Balzar, Elizabeth Ampleford, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2011
Obesity and asthma: an association modified by age of asthma onsetFernando Holguin, Eugene R Bleecker, William W Busse, et al.
BMC Pulmonary Medicine|May 18, 2016
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the NetherlandsThys van der Molen, Dirkje S Postma, Richard J Martin, et al.
The Lancet. Respiratory Medicine|March 14, 2014
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic studyVictor E Ortega, Gregory A Hawkins, Wendy C Moore, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2021
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research ProgramAnnette T Hastie, David T Mauger, Loren C Denlinger, et al.
BMC Pulmonary Medicine|July 25, 2016
Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the NetherlandsThys van der Molen, Dirkje S Postma, Richard J Martin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 22, 2018
Predictors of inhaled corticosteroid taper failure in adults with asthmaJuan Carlos Cardet, Christopher D Codispoti, Tonya S King, et al.
Human Molecular Genetics|May 7, 2004
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroidsKelan G Tantisira, Stephen Lake, Eric S Silverman, et al.
Pageof 33